Table 1.
Patient characteristics.
| Patient | Age | Sex | Ejection fraction (%) | Cause of death/medications |
|---|---|---|---|---|
| Control 1 | 52 | M | Cerebral hemorrhage | |
| Control 2 | 21 | M | Unknown | |
| Control 3 | 55 | M | Aortic aneurysm | |
| Control 4 | 65 | M | Aortic aneurysm | |
| Control 5 | 61 | M | Unknown | |
| Control 6 | 56 | M | Cerebral hemorrhage | |
| Control 7 | 47 | M | Unknown | |
| Control 8 | 54 | M | Crush injury | |
| Control 9 | 41 | M | Unknown | |
| Control 10 | 44 | M | Unknown | |
| HF1 | 58 | F | 10 | Amiodarone, bumetanide, furosemide, losartan, metolazone, metoprolol, milrinone, potassium, simvastatin, spirinolactone |
| HF2 | 60 | M | 10 | Aspirin, carvedilol, furosemide, simvastatin |
| HF3 | 41 | M | 20 | Aspirin, carvedilol, furosemide, lisinopril, potassium |
| HF4 | 72 | M | 10 | Digoxin, ezetimibe, metropolol, milrinone, potassium, pravastatin, spirinolactone |
| HF5 | 55 | M | 15 | Aspirin, carvedilol, digoxin, furosemide, lisinopril, potassium, spirinolactone |
| HF6 | 75 | M | 20 | Amiodarone, carvedilol, digoxin, furosemide, metolazone, potassium, spirinolactone |
| HF7 | 68 | M | 35 | Aspirin, furosemide, lisinopril, metoprolol, simvastatin |
| HF8 | 39 | M | 20 | Amiodarone, aspirin, carvedilol, furosemide, lisinopril, potassium, spirinolactone |
| HF9 | 37 | M | 15 | Amiodarone, aspirin, carvedilol, digoxin, losartan, furosemide, milrinone, spirinolactone, simvastatin |
| HF10 | 74 | M | 25 | Aspirin, carvedilol, digoxin, furosemide, isosorbide dinitrate, lisinopril, niacin |